Psyence Ebt Per Ebit from 2010 to 2024

PBMWW Stock   0.01  0.0005  6.76%   
Psyence Biomedical Ebt Per Ebit yearly trend continues to be fairly stable with very little volatility. Ebt Per Ebit will likely drop to 0.83 in 2024. During the period from 2010 to 2024, Psyence Biomedical Ebt Per Ebit regression line of quarterly data had mean square error of  0 and geometric mean of  1.00. View All Fundamentals
 
Ebt Per Ebit  
First Reported
2010-12-31
Previous Quarter
1.11669338
Current Value
0.83
Quarterly Volatility
0.05515654
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Psyence Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Psyence Biomedical's main balance sheet or income statement drivers, such as Interest Income of 1.4 K, Selling General Administrative of 1.8 M or Selling And Marketing Expenses of 84.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Ptb Ratio of 0.0 or Days Sales Outstanding of 0.0. Psyence financial statements analysis is a perfect complement when working with Psyence Biomedical Valuation or Volatility modules.
  
Check out the analysis of Psyence Biomedical Correlation against competitors.

Latest Psyence Biomedical's Ebt Per Ebit Growth Pattern

Below is the plot of the Ebt Per Ebit of Psyence Biomedical Ltd over the last few years. It is Psyence Biomedical's Ebt Per Ebit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Psyence Biomedical's overall financial position and show how it may be relating to other accounts over time.
Ebt Per Ebit10 Years Trend
Pretty Stable
   Ebt Per Ebit   
       Timeline  

Psyence Ebt Per Ebit Regression Statistics

Arithmetic Mean1.00
Geometric Mean1.00
Coefficient Of Variation5.53
Mean Deviation0.02
Median1.00
Standard Deviation0.06
Sample Variance0
Range0.2867
R-Value(0.17)
Mean Square Error0
R-Squared0.03
Significance0.55
Slope(0)
Total Sum of Squares0.04

Psyence Ebt Per Ebit History

2024 0.83
2023 1.12
2022 0.99

About Psyence Biomedical Financial Statements

Psyence Biomedical investors use historical fundamental indicators, such as Psyence Biomedical's Ebt Per Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Psyence Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Ebt Per Ebit 1.12  0.83 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Psyence Stock Analysis

When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.